Justin Boggs is a writer for the E.W. Scripps company. Justin covers anything from politics to sports and entertainment.
Pharmaceutical company AstraZeneca said the Food and Drug Administration has accepted an application to consider allowing FluMist Quadrivalent to become the first flu vaccine available to be self-administered by patients.
If granted final approval by the FDA, the vaccine could allow patients ages 18-49 an opportunity to administer a flu vaccine on their own without a doctor or pharmacist. It would also allow caregivers of those ages 2-49 the ability to administer the vaccine. "A self-administered option for FluMist Quadrivalent would leverage the unique attributes of the product, providing a convenient new choice for individuals and families who want to protect their loved ones against flu," Dr.
The FDA first approved use of the nasal flu vaccine in 2003 for those ages 5-49. In 2007, the FDA expanded its approval for those ages 2-5. It is currently only allowed to be administered in health care settings. The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices noted that studies from 2013-16 noted a lower effectiveness rate of FluMist Quadrivalent compared to injectable flu vaccines. The committee voted in 2016 that the vaccine should not have been used for the 2016-17 flu season. According to the CDC, 57.4% of children ages 6 months through 17 years got a flu shot in the 2022-23 season. It was the lowest flu vaccination rate among children since 2012-13.
About 62.5% of pediatric flu vaccines in 2022-23 were administered at doctor's offices, while 16.9% were administered at pharmacies and 11.5% at clinics and health centers, the CDC said. The percentage of children getting vaccinated at pharmacies has more than doubled in the last five years.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Jim Jordan ousted as Republicans' speaker-designeeJustin Boggs is a writer for the E.W. Scripps company. Justin covers anything from politics to sports and entertainment.
Read more »
Cost of health care rises as open enrollment season beginsJustin Boggs is a writer for the E.W. Scripps company. Justin covers anything from politics to sports and entertainment.
Read more »
What are the most popular Halloween costumes for 2023?Justin Boggs is a writer for the E.W. Scripps company. Justin covers anything from politics to sports and entertainment.
Read more »
Report shows toddler formulas offer no nutritional advantageJustin Boggs is a writer for the E.W. Scripps company. Justin covers anything from politics to sports and entertainment.
Read more »
Jayvan Boggs, Eli Lee and thoughts on Ohio State’s big recruiting weekend: Buckeye Talk PodcastStephen Means and Andrew Gillis discuss Ohio State recruiting.
Read more »
How 2025 Ohio State WR commit Jayvan Boggs is drawing comparisons to a former first-round Buckeye wideoutOhio State wide receiver commit Jayvan Boggs is drawing comparisons
Read more »